DK167140B1 - Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum og fremgangsmaade til dets fremstilling i form af et implantat - Google Patents

Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum og fremgangsmaade til dets fremstilling i form af et implantat Download PDF

Info

Publication number: DK167140B1
Authority: DK; Denmark
Prior art keywords: peptide; implant; fatty acid; trp; biodegradable
Prior art date: 1985-07-29

Application number

DK350286A

Other languages

Danish (da)

English (en)

Other versions

DK350286D0 (da

DK350286A (da

Inventor

Susan Mancini Cady

Richard Fishbein

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-07-29

Filing date

1986-07-23

Publication date

1993-09-06

1986-07-23 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1986-07-23 Publication of DK350286D0 publication Critical patent/DK350286D0/da

1987-01-30 Publication of DK350286A publication Critical patent/DK350286A/da

1993-09-06 Application granted granted Critical

1993-09-06 Publication of DK167140B1 publication Critical patent/DK167140B1/da

Links

239000007943 implant Substances 0.000 title claims description 46
238000000034 method Methods 0.000 title claims description 12
238000002360 preparation method Methods 0.000 title abstract description 7
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 40
239000000203 mixture Substances 0.000 claims abstract description 19
238000007911 parenteral administration Methods 0.000 claims abstract description 5
238000000576 coating method Methods 0.000 claims description 24
235000014113 dietary fatty acids Nutrition 0.000 claims description 24
239000000194 fatty acid Substances 0.000 claims description 24
229930195729 fatty acid Natural products 0.000 claims description 24
150000003839 salts Chemical class 0.000 claims description 23
239000011248 coating agent Substances 0.000 claims description 19
-1 fatty acid salt Chemical class 0.000 claims description 13
150000004665 fatty acids Chemical class 0.000 claims description 11
239000000463 material Substances 0.000 claims description 9
WZHKXNSOCOQYQX-FUAFALNISA-N (2s)-6-amino-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Chemical compound C([C@H](N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CN=CN1 WZHKXNSOCOQYQX-FUAFALNISA-N 0.000 claims description 7
125000004432 carbon atom Chemical group C* 0.000 claims description 2
230000002035 prolonged effect Effects 0.000 claims description 2
239000000243 solution Substances 0.000 description 16
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
239000011521 glass Substances 0.000 description 9
238000001727 in vivo Methods 0.000 description 8
238000004090 dissolution Methods 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
229920000642 polymer Polymers 0.000 description 5
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 4
JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 4
229920001577 copolymer Polymers 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
239000000314 lubricant Substances 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
239000000047 product Substances 0.000 description 3
229920005573 silicon-containing polymer Polymers 0.000 description 3
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
UIQWBVPFHHQZHH-UHFFFAOYSA-N OOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOO UIQWBVPFHHQZHH-UHFFFAOYSA-N 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
239000000908 ammonium hydroxide Substances 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
238000007906 compression Methods 0.000 description 2
230000006835 compression Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001035 drying Methods 0.000 description 2
210000003608 fece Anatomy 0.000 description 2
239000005457 ice water Substances 0.000 description 2
238000002513 implantation Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
238000005303 weighing Methods 0.000 description 2
VKSWWACDZPRJAP-UHFFFAOYSA-N 1,3-dioxepan-2-one Chemical compound O=C1OCCCCO1 VKSWWACDZPRJAP-UHFFFAOYSA-N 0.000 description 1
WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
101100515517 Arabidopsis thaliana XI-I gene Proteins 0.000 description 1
101100228200 Caenorhabditis elegans gly-5 gene Proteins 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
KUGRPPRAQNPSQD-UHFFFAOYSA-N OOOOO Chemical compound OOOOO KUGRPPRAQNPSQD-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000036765 blood level Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229930002875 chlorophyll Natural products 0.000 description 1
235000019804 chlorophyll Nutrition 0.000 description 1
ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
239000012738 dissolution medium Substances 0.000 description 1
210000000624 ear auricle Anatomy 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000000921 elemental analysis Methods 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
239000011888 foil Substances 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
239000003517 fume Substances 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000002690 local anesthesia Methods 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
229940045950 pep-20 Drugs 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229920001432 poly(L-lactide) Polymers 0.000 description 1
UAJUXJSXCLUTNU-UHFFFAOYSA-N pranlukast Chemical compound C=1C=C(OCCCCC=2C=CC=CC=2)C=CC=1C(=O)NC(C=1)=CC=C(C(C=2)=O)C=1OC=2C=1N=NNN=1 UAJUXJSXCLUTNU-UHFFFAOYSA-N 0.000 description 1
229960004583 pranlukast Drugs 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000004064 recycling Methods 0.000 description 1
229920000260 silastic Polymers 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Zoology (AREA)
Toxicology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cephalosporin Compounds (AREA)
Macromonomer-Based Addition Polymer (AREA)

DK350286A 1985-07-29 1986-07-23 Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum og fremgangsmaade til dets fremstilling i form af et implantat DK167140B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US75970185A	1985-07-29	1985-07-29
US75970185		1985-07-29

Publications (3)

Publication Number	Publication Date
DK350286D0 DK350286D0 (da)	1986-07-23
DK350286A DK350286A (da)	1987-01-30
DK167140B1 true DK167140B1 (da)	1993-09-06

Family

ID=25056640

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK350286A DK167140B1 (da)	1985-07-29	1986-07-23	Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum og fremgangsmaade til dets fremstilling i form af et implantat

Country Status (16)

Country	Link
EP (1)	EP0211267B1 (fr)
JP (1)	JPH0764740B2 (fr)
KR (1)	KR900005902B1 (fr)
AT (1)	ATE58838T1 (fr)
AU (1)	AU587626B2 (fr)
CA (1)	CA1277596C (fr)
DE (1)	DE3675996D1 (fr)
DK (1)	DK167140B1 (fr)
ES (1)	ES8801878A1 (fr)
FI (1)	FI85812C (fr)
GR (1)	GR861984B (fr)
IE (1)	IE59276B1 (fr)
IL (1)	IL79134A (fr)
NO (1)	NO171396C (fr)
NZ (1)	NZ216882A (fr)
ZA (1)	ZA865628B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2209937B (en) *	1987-09-21	1991-07-03	Depiopharm S A	Water insoluble polypeptides
AU618029B2 (en) *	1987-11-02	1991-12-12	Imperial Chemical Industries Plc	Polypeptide compounds
DE68922602T2 (de) *	1988-01-28	1995-12-07	Polygen Holding Corp	Polypeptide mit hormonwachstumsbefreiender wirkung.
GB8813356D0 (en) *	1988-06-06	1988-07-13	Ici Plc	Polypeptide compounds
US4964892A (en) *	1988-12-22	1990-10-23	Rohm And Haas Company	Synergistic microbicidal combinations containing 2-N-octyl-3-isothiazolone and certain commercial biocides
US5439688A (en) *	1989-07-28	1995-08-08	Debio Recherche Pharmaceutique S.A.	Process for preparing a pharmaceutical composition
US5225205A (en) *	1989-07-28	1993-07-06	Debiopharm S.A.	Pharmaceutical composition in the form of microparticles
CH679207A5 (fr) *	1989-07-28	1992-01-15	Debiopharm Sa
CH683149A5 (fr) *	1991-07-22	1994-01-31	Debio Rech Pharma Sa	Procédé pour la préparation de microsphères en matériau polymère biodégradable.
IE20100174A1 (en) *	2010-03-25	2012-02-29	Trinity College Dublin	Transdermal administration of peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2517513A (en) *	1943-02-27	1950-08-01	Vaernet Carl	Pharmaceutical preparation for implantation
US4411890A (en) *	1981-04-14	1983-10-25	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
US3872714A (en) *	1974-01-29	1975-03-25	Gen Signal Corp	Method and apparatus for testing a valve
DE2752341A1 (de) *	1976-11-23	1978-05-24	Wellcome Found	Biologisch wirksame amide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische formulierungen
DE2902414A1 (de) *	1979-01-23	1980-08-07	Hoechst Ag	Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
DE3045135A1 (de) *	1980-11-29	1982-06-09	Sandoz-Patent-GmbH, 7850 Lörrach	Pharmazeutische kompositionen enthaltende bioabbaubare polymere
JPS57134412A (en) *	1981-02-12	1982-08-19	Unitika Ltd	Biodegradable drug donor
HUT35524A (en) *	1983-08-02	1985-07-29	Hoechst Ag	Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3413608A1 (de) *	1984-04-11	1985-10-24	Hoechst Ag, 6230 Frankfurt	Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung

1986
- 1986-06-16 IL IL79134A patent/IL79134A/xx not_active IP Right Cessation
- 1986-06-25 ES ES556762A patent/ES8801878A1/es not_active Expired
- 1986-07-10 DE DE8686109446T patent/DE3675996D1/de not_active Expired - Fee Related
- 1986-07-10 AT AT86109446T patent/ATE58838T1/de not_active IP Right Cessation
- 1986-07-10 EP EP86109446A patent/EP0211267B1/fr not_active Expired - Lifetime
- 1986-07-17 NZ NZ216882A patent/NZ216882A/en unknown
- 1986-07-23 DK DK350286A patent/DK167140B1/da not_active IP Right Cessation
- 1986-07-25 CA CA000514656A patent/CA1277596C/fr not_active Expired - Lifetime
- 1986-07-28 FI FI863078A patent/FI85812C/fi not_active IP Right Cessation
- 1986-07-28 JP JP61175813A patent/JPH0764740B2/ja not_active Expired - Lifetime
- 1986-07-28 AU AU60619/86A patent/AU587626B2/en not_active Expired
- 1986-07-28 IE IE199386A patent/IE59276B1/en not_active IP Right Cessation
- 1986-07-28 KR KR1019860006166A patent/KR900005902B1/ko not_active Expired
- 1986-07-28 ZA ZA865628A patent/ZA865628B/xx unknown
- 1986-07-28 NO NO863027A patent/NO171396C/no not_active IP Right Cessation
- 1986-07-29 GR GR861984A patent/GR861984B/el unknown

Also Published As

Publication number	Publication date
GR861984B (en)	1986-12-29
EP0211267A2 (fr)	1987-02-25
ZA865628B (en)	1987-03-25
ES556762A0 (es)	1988-03-16
EP0211267B1 (fr)	1990-12-05
JPH0764740B2 (ja)	1995-07-12
DE3675996D1 (de)	1991-01-17
KR870000933A (ko)	1987-03-10
NO171396C (no)	1993-03-10
NO171396B (no)	1992-11-30
DK350286D0 (da)	1986-07-23
IE59276B1 (en)	1994-02-09
NO863027D0 (no)	1986-07-28
IE861993L (en)	1987-01-29
ES8801878A1 (es)	1988-03-16
KR900005902B1 (ko)	1990-08-16
FI85812B (fi)	1992-02-28
CA1277596C (fr)	1990-12-11
FI863078A0 (fi)	1986-07-28
AU587626B2 (en)	1989-08-24
NO863027L (no)	1987-01-30
IL79134A0 (en)	1986-09-30
JPS6229531A (ja)	1987-02-07
NZ216882A (en)	1988-05-30
FI85812C (fi)	1992-06-10
AU6061986A (en)	1987-02-05
DK350286A (da)	1987-01-30
IL79134A (en)	1991-06-10
ATE58838T1 (de)	1990-12-15
EP0211267A3 (en)	1987-10-14
FI863078L (fi)	1987-01-30

Legal Events

Date	Code	Title	Description
1993-09-06	B1	Patent granted (law 1993)
2005-02-28	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
DK167140B1 (da)	1993-09-06	Praeparat til parenteral indgivelse af et peptid over et laengere tidsrum og fremgangsmaade til dets fremstilling i form af et implantat
US7976858B2 (en)	2011-07-12	Drug delivery to a joint
US4200939A (en)	1980-05-06	Method for fixation of prostheses to bone
US8158143B2 (en)	2012-04-17	Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect
JP5684140B2 (ja)	2015-03-11	アスコルビン酸リン酸塩の持続放出系
DK174992B1 (da)	2004-04-13	Farmaceutisk præparat med langsom frigivelse samt anvendelse af visse additiver i sådanne til opnåelse af langsom frigivelse
TW200814992A (en)	2008-04-01	Stabilized pharmaceutical compositions comprising fesoterodine
US20050129732A1 (en)	2005-06-16	Biodegradable, antibiotic, controlled release tape
ES2305524T3 (es)	2008-11-01	Sistema de aporte controlado de sustancias bioactivas.
US20070026527A1 (en)	2007-02-01	Means for detecting pathological transformation of the app protein and their uses
EP0901796A2 (fr)	1999-03-17	Dispositif d'encapsulation
WO2011131370A1 (fr)	2011-10-27	Fingolimod granulé fondu
Huhtala et al.	2008	In vitro biocompatibility of degradable biopolymers in cell line cultures from various ocular tissues: extraction studies
Sharma et al.	2020	Potential applications of Abelmoschus moschatus polysaccharide as colon release tablets-Rheology and gamma scintigraphic study
US5137874A (en)	1992-08-11	Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
WO2023161792A1 (fr)	2023-08-31	Formulations de caprate de sodium compressible
Zhu et al.	2004	Examination of aqueous oxidized cellulose dispersions as a potential drug carrier: II. In vitro and in vivo evaluation of phenylpropanolamine release from microparticles and pellets
Zhou et al.	2010	Biological evaluation of poly-l-lactic acid composite containing bioactive glass
Pinals	1970	Nodular panniculitis associated with an inflammatory bone lesion
RU2795082C1 (ru)	2023-04-28	Способ получения кальцийфосфатного матрикса на основе самосхватывающейся композиции с антибактериальными свойствами для коррекции патологии опорно-двигательной системы пациента
CN108785246A (zh)	2018-11-13	二甲双胍缓释剂型及制备方法以及注射剂及应用
Török et al.	1975	Resorption of 125l-Labeled Fibrin Bioplast from the Dorsal Muscle of Rats
Judge et al.	1981	Sustained-release implants in the chemotherapy of experimental rodent malaria II: The effects of sulphadiazine, pyrimethamine and cycloguanil in biodegradable polymer matrices
WO2004091587A1 (fr)	2004-10-28	Liberation multiple de medicaments anti-diabete et procede de production associe
Karakurt et al.	2004	Muscular infarction of the thigh in a diabetic patient: a case report